Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00365989 · ClinicalTrials.gov registry record · Phase 3
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
A Phase 3 study, sponsored by InSightec.
- Completed
- Registry status
- Phase 3
- Development phase
- 50
- Enrollment target
NCT00365989: Completed Phase 3 study, sponsored by InSightec.
NCT00365989 is a Phase 3 study that has completed, run by InSightec. The registered enrollment target is 50 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00365989, a Phase 3 study, has completed, sponsored by InSightec.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a phase 3 study to determine the safety of the new features to the FDA approved ExAblate device using a new method to ablate fibroids deemed Enhanced Sonication.
Primary Outcome
The study objective is to determine the safety of the new Enhanced Sonication technique and assure no new safety issues are introduced.
Interventions
- DEVICE ExAblate Enhanced Sonication
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2006-10 |
| Est. Completion | 2008-08 |
| Phase | Phase 3 |
What the finished NCT00365989 record still lists
NCT00365989 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which ExAblate Enhanced Sonication is the first listed.
NCT00365989 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00365989 about?
NCT00365989 is a clinical study titled "MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication". This is a phase 3 study to determine the safety of the new features to the FDA approved ExAblate device using a new method to ablate fibroids deemed Enhanced Sonication.
What is the current status of trial NCT00365989?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 50 participants. The study started on 2006-10. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00365989?
The interventions under investigation include: ExAblate Enhanced Sonication (DEVICE).
Who is sponsoring clinical trial NCT00365989?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00365989's enrollment target sits among peer trials
50 1844th of 2000 higher than 141 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia